{"id":9054,"date":"2019-11-27T20:10:00","date_gmt":"2019-11-27T20:10:00","guid":{"rendered":"https:\/\/polpharmabiologics.com\/?p=9054"},"modified":"2025-03-25T15:29:59","modified_gmt":"2025-03-25T15:29:59","slug":"bioceros-develops-monoclonal-antibodies-as-a-division-of-polpharma-biologics-group","status":"publish","type":"post","link":"https:\/\/polpharmabiologics.com\/pl\/bioceros-develops-monoclonal-antibodies-as-a-division-of-polpharma-biologics-group\/","title":{"rendered":"Bioceros develops monoclonal antibodies as a division of Polpharma Biologics Group"},"content":{"rendered":"\n<p>Dr. Louis Boon, Chief Scientific Officer of Bioceros (division of Polpharma Biologics Group), talked about Bioceros CHOBC\u00ae own platform and explains how SPOT &amp; SLIM technology boost specific productivity and make the process more efficient.<\/p>\n\n\n\n<p>Speaking at BIO-Europe\u00ae 2019 in Hamburg, Dr. Boon cited two recent partnerships, one with Sandoz for commercialization of a Natalizumab biosimilar, and an agreement with Coherus. Bioceros\u2019 services are available on a modular basis, fully adjustable to clients\u2019 requests, working together with Polpharma Biologics to offer a truly integrated biopharmaceutical one-stop-shop approach.<\/p>\n\n\n\n<p>For more information, listen to an interview with Dr. Louis Boon:<\/p>\n\n\n\n<p><strong><a href=\"https:\/\/youtu.be\/421ntt3ud_I\">Watch full video here<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Louis Boon, Chief Scientific Officer of Bioceros (division of Polpharma Biologics Group), talked about Bioceros C&#8230;<\/p>\n","protected":false},"author":7,"featured_media":7282,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[33],"class_list":["post-9054","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-artykuly","tag-wywiady"],"_links":{"self":[{"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/posts\/9054","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/comments?post=9054"}],"version-history":[{"count":0,"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/posts\/9054\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/media\/7282"}],"wp:attachment":[{"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/media?parent=9054"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/categories?post=9054"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/polpharmabiologics.com\/pl\/wp-json\/wp\/v2\/tags?post=9054"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}